Ticker
AMPHCompany Name
AMPHASTAR PHARMACEUTICALS INCSector
HealthcareIndustry
Drug Manufacturers - Specialty & GenericExchange
NASDAQDate | Net Cash Flow - Operations | Operating Cash Flow Margin | Revenues |
---|---|---|---|
6/30/2025 | $ 159.66M | 22.09% | $ 722.68M |
3/31/2025 | $ 193.17M | 26.44% | $ 730.66M |
12/31/2024 | $ 213.39M | 29.15% | $ 731.97M |
9/30/2024 | $ 208.23M | 28.78% | $ 723.55M |
6/30/2024 | $ 212.6M | 29.82% | $ 712.89M |
3/31/2024 | $ 198.41M | 29.34% | $ 676.21M |
12/31/2023 | $ 183.5M | 28.48% | $ 644.39M |
9/30/2023 | $ 174.87M | 29.08% | $ 601.31M |
6/30/2023 | $ 130.91M | 24.2% | $ 540.89M |
3/31/2023 | $ 78.8M | 15.19% | $ 518.64M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
CF - Operations / Revenues
(=) OCF %
OCF % for AMPHASTAR PHARMACEUTICALS INC is calculated as follows: CF - Operations [ $ 46.02M ] / Revenues [ $ 337.31M ]
(=) OCF % [ 13.64% ]
Minimum
Sep 30, 2020
Maximum
Jun 30, 2024
Average
Median
filtered constituents | 3.25K |
---|---|
min | -57.27% |
max | 77.08% |
average | 14.31% |
median | 12.65% |
std | 21.13% |